SLNO — Soleno Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00
- $1.41bn
- $1.27bn
- 46
- 20
- 83
- 48
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -30.8 | -24.6 | -30.9 | -24.1 | -39 |
Depreciation | |||||
Non-Cash Items | 8.94 | -5.51 | 2.33 | 2.08 | 9.16 |
Other Non-Cash Items | |||||
Changes in Working Capital | 2.5 | 2.98 | -1.15 | -0.756 | 2.93 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -17.4 | -25.2 | -27.8 | -20.8 | -24.9 |
Capital Expenditures | -0.021 | -0.007 | -0.022 | -0.013 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.549 | 0 | — | — | — |
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0.528 | -0.007 | -0.022 | -0.013 | 0 |
Financing Cash Flow Items | — | — | -0.12 | -1.06 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 14.5 | 53.7 | -0.128 | 14.1 | 180 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -2.37 | 28.5 | -27.9 | -6.7 | 155 |